Elisabeth Boichot Selected Research

piclamilast

3/2005	Selective PDE4 inhibitors as potent anti-inflammatory drugs for the treatment of airway diseases.
4/2002	The selective phosphodiesterase 4 inhibitor RP 73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-beta release during acute lung injury in mice: the role of the balance between Tumor necrosis factor-alpha and interleukin-10.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisabeth Boichot Research Topics

Disease

6	Chronic Obstructive Pulmonary Disease (COPD) 01/2016 - 03/2005
5	Fibrosis (Cirrhosis) 07/2019 - 02/2006
5	Inflammation (Inflammations) 01/2016 - 04/2002
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2014 - 01/2005
3	Airway Remodeling 03/2005 - 04/2002
2	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2010 - 03/2009
2	Emphysema 03/2009 - 01/2008
2	Lung Diseases (Lung Disease) 03/2009 - 03/2005
2	Pneumonia (Pneumonitis) 01/2008 - 03/2007
2	Lung Injury 03/2005 - 03/2005
1	Gout 04/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Liver Diseases (Liver Disease) 01/2016
1	Asthma (Bronchial Asthma) 03/2005
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2003
1	Acute Lung Injury 04/2002

Drug/Important Bio-Agent (IBA)

11	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 04/2002
3	Metalloproteases (Metalloproteinases)IBA 01/2016 - 02/2003
3	SmokeIBA 01/2014 - 01/2008
3	Bleomycin (Blenoxane)FDA LinkGeneric 07/2007 - 01/2005
2	InflammasomesIBA 07/2019 - 01/2016
2	Purinergic Receptors (Receptors, Purine)IBA 04/2017 - 01/2016
2	Interleukin-1 (Interleukin 1)IBA 01/2016 - 01/2008
2	CollagenIBA 01/2016 - 04/2014
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 01/2005
2	CytokinesIBA 01/2014 - 03/2005
2	Matrix Metalloproteinase 12IBA 03/2009 - 02/2006
2	piclamilastIBA 03/2005 - 04/2002
2	Phosphodiesterase 4 InhibitorsIBA 03/2005 - 04/2002
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2016
1	Infliximab (Remicade)FDA Link 01/2016
1	roflumilast N-oxideIBA 01/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2016
1	ElastinIBA 03/2009
1	Pancreatic Elastase (Elastase)IBA 03/2009
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2008
1	Toll-Like Receptor 4IBA 01/2008
1	indium-bleomycinIBA 07/2007
1	Matrix Metalloproteinase InhibitorsIBA 03/2007
1	RolipramIBA 03/2007
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2007
1	marimastatIBA 03/2007
1	CI 1044IBA 03/2005
1	RoflumilastIBA 03/2005
1	CilomilastIBA 03/2005
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2005
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2005
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2005
1	LipopolysaccharidesIBA 07/2004
1	Albuterol (Salbutamol)FDA LinkGeneric 07/2004
1	NitratesIBA 07/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2004
1	Tissue Inhibitor of Metalloproteinase-1IBA 02/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2002
1	Interleukin-10 (Interleukin 10)IBA 04/2002
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2002
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 04/2002
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2002
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2002

Therapy/Procedure

1	Therapeutics 01/2016